Suchergebnisse - "Mosenzon, Ofri"

PubPharm (185)

1

The Importance of Early Diagnosis and Intervention in Chronic Kidney Disease : Calls-to-Action from Nephrologists Based Mainly in Central/Eastern Europe

enthalten in: Kidney & blood pressure research | 2024

von Covic, A. | Säemann, M. | Filipov, J. | +12

2

The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone : Post hoc analysis of the FIDELITY study

enthalten in: Diabetes, obesity & metabolism | 2023

von Rossing, P. | Anker, S. | Filippatos, G. | +12

3

Risk of hospitalization with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease : Real-world data

enthalten in: Diabetes, obesity & metabolism | 2023

von Schechter, M. | Melzer Cohen, C. | Zelter, T. | +5

4

Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes

enthalten in: Diabetes care | 2023

von Moura, F. | Berg, D. | Bellavia, A. | +10

5

Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2023

von Melzer Cohen, C. | Schechter, M. | Rozenberg, A. | +7

CommentIn: Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1119-1121. - PMID 37498620

6

The authors reply

enthalten in: Kidney international | 2023

von Tuttle, K. | Bosch-Traberg, H. | Cherney, D. | +4

CommentOn: Kidney Int. 2023 Sep;104(3):618-619. - PMID 37599022

7

Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin

enthalten in: The New England journal of medicine | 2023

von Rosenstock, J. | Bain, S. | Gowda, A. | +107

CommentIn: Ann Intern Med. 2023 Oct;176(10):JC113. - PMID 37782932

8

Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes : real-world evidence

enthalten in: Cardiovascular diabetology | 2023

von Schechter, M. | Melzer Cohen, C. | Fishkin, A. | +9

9

Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence

enthalten in: Cardiovascular diabetology | 2023

von Schechter, M. | Melzer Cohen, C. | Fishkin, A. | +9

10

Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes : A Secondary Analysis of the DECLARE-TIMI 58 Trial

enthalten in: JAMA cardiology | 2023

von Zelniker, T. | Wiviott, S. | Mosenzon, O. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]